{"id":5876,"date":"2026-05-13T17:12:06","date_gmt":"2026-05-13T17:12:06","guid":{"rendered":"https:\/\/odakhaber.site\/?p=5876"},"modified":"2026-05-13T17:12:06","modified_gmt":"2026-05-13T17:12:06","slug":"obezite-tedavisinde-yeni-donem-zayiflama-ignesini-birakanlar-icin-kilo-koruma-hapi-geldi","status":"publish","type":"post","link":"https:\/\/odakhaber.site\/?p=5876","title":{"rendered":"Obezite Tedavisinde Yeni D\u00f6nem: Zay\u0131flama \u0130\u011fnesini B\u0131rakanlar \u0130\u00e7in &#8220;Kilo Koruma&#8221; Hap\u0131 Geldi"},"content":{"rendered":"\n<p>Kilo verme s\u00fcrecinde enjeksiyon tedavisini tamamlayan hastalar\u0131n en b\u00fcy\u00fck korkusu olan &#8220;yeniden kilo alma&#8221; sorununa kar\u015f\u0131 bilim d\u00fcnyas\u0131ndan umut verici bir haber geldi. <strong>Orforglipron<\/strong> ad\u0131 verilen yeni bir hap\u0131n, zay\u0131flama i\u011fnelerini b\u0131rakan ki\u015filerin verdi\u011fi kilolar\u0131 muhafaza etmesini sa\u011flad\u0131\u011f\u0131 a\u00e7\u0131kland\u0131.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Klinik Deneylerde Ba\u015far\u0131: Kilolar\u0131n %70&#8217;i Korunuyor<\/h3>\n\n\n\n<p><strong>Nature Medicine<\/strong> dergisinde yay\u0131mlanan ve <strong>Eli Lilly<\/strong> taraf\u0131ndan finanse edilen ara\u015ft\u0131rma, GLP-1 bazl\u0131 enjeksiyonlar\u0131 (Mounjaro veya Wegovy gibi) b\u0131rakan 376 ki\u015fi \u00fczerinde ger\u00e7ekle\u015ftirildi. Bir y\u0131l s\u00fcren takip \u00e7al\u0131\u015fmalar\u0131 sonucunda \u00e7arp\u0131c\u0131 veriler elde edildi:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Orforglipron Kullananlar:<\/strong> Verdikleri kilonun <strong>%70\u2019inden fazlas\u0131n\u0131<\/strong> korumay\u0131 ba\u015fard\u0131.<\/li>\n\n\n\n<li><strong>Plasebo Grubu:<\/strong> Kilo koruma oran\u0131 <strong>%38 ila %50<\/strong> aras\u0131nda kalarak daha d\u00fc\u015f\u00fck performans sergiledi.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">&#8220;Obezite Kronik Bir Hastal\u0131kt\u0131r&#8221;<\/h3>\n\n\n\n<p>Uzmanlar, bu geli\u015fmenin obeziteye bak\u0131\u015f a\u00e7\u0131s\u0131n\u0131 de\u011fi\u015ftirdi\u011fini vurguluyor. University of Cambridge\u2019den kilo y\u00f6netimi uzman\u0131 <strong>Dr. Marie Spreckley<\/strong>, hap formundaki tedavinin enjeksiyona g\u00f6re \u00e7ok daha cazip oldu\u011funu belirterek, <em>&#8220;Obezitenin kronik ve tekrarlayan bir hastal\u0131k oldu\u011funa ili\u015fkin yakla\u015f\u0131m g\u00fc\u00e7leniyor&#8221;<\/em> de\u011ferlendirmesinde bulundu.<\/p>\n\n\n\n<p>Anglia Ruskin University\u2019nden <strong>Dr. Simon Cork<\/strong> ise ilac\u0131n sadece kilo korumad\u0131\u011f\u0131n\u0131, ayn\u0131 zamanda \u015fu de\u011ferleri de iyile\u015ftirdi\u011fini ifade etti:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kan \u015fekeri dengesi<\/li>\n\n\n\n<li>Tansiyon kontrol\u00fc<\/li>\n\n\n\n<li>Lipid seviyeleri<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Ekonomik ve Eri\u015filebilir Alternatif<\/h3>\n\n\n\n<p>Mevcut zay\u0131flama i\u011fnelerinin ayl\u0131k maliyeti 1000 dolar\u0131n \u00fczerine \u00e7\u0131kabilirken, <strong>Orforglipron<\/strong>&#8216;un ABD\u2019deki en d\u00fc\u015f\u00fck doz sat\u0131\u015f fiyat\u0131 ayl\u0131k yakla\u015f\u0131k <strong>149 dolar<\/strong> olarak belirlendi. Bu durum, hap tedavisinin \u00e7ok daha ekonomik bir alternatif olabilece\u011fini g\u00f6steriyor.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>Nas\u0131l \u00c7al\u0131\u015f\u0131yor?<\/strong><\/p>\n\n\n\n<p>Orforglipron, v\u00fccuttaki do\u011fal GLP-1 hormonunu taklit ederek i\u015ftah\u0131 bask\u0131l\u0131yor ve tokluk hissini uzat\u0131yor. Hap formunda olmas\u0131na ra\u011fmen, mevcut i\u011fne tedavileriyle benzer mekanizmaya sahip.<\/p>\n<\/blockquote>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Dikkat Edilmesi Gerekenler ve Yan Etkiler<\/h3>\n\n\n\n<p>Her ne kadar sonu\u00e7lar heyecan verici olsa da, ilac\u0131n kullan\u0131m\u0131nda baz\u0131 yan etkiler g\u00f6zlemlendi. Ara\u015ft\u0131rmada en yayg\u0131n g\u00f6r\u00fclen \u015fikayetler \u015funlar oldu:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mide bulant\u0131s\u0131<\/li>\n\n\n\n<li>Kab\u0131zl\u0131k<\/li>\n\n\n\n<li>\u0130shal<\/li>\n<\/ul>\n\n\n\n<p>Uzmanlar, bu tedavinin tam olarak ne kadar s\u00fcreyle kullan\u0131lmas\u0131 gerekti\u011fini netle\u015ftirmek i\u00e7in daha kapsaml\u0131 ara\u015ft\u0131rmalara ihtiya\u00e7 duyuldu\u011funu hat\u0131rlat\u0131yor. \u00d6te yandan, rakip \u00fcretici <strong>Novo Nordisk<\/strong>&#8216;in geli\u015ftirdi\u011fi Wegovy hap formunun da ABD onay\u0131 ald\u0131\u011f\u0131, \u0130ngiltere\u2019deki s\u00fcrecin ise devam etti\u011fi bildirildi.<\/p>\n\n\n\n<p><a href=\"https:\/\/gazeteoksijen.com\/saglik\/istahi-baskiliyor-zayiflama-ignesi-sonrasi-kilo-alimini-onleyen-hap-gelistirildi-275299\">https:\/\/gazeteoksijen.com\/saglik\/istahi-baskiliyor-zayiflama-ignesi-sonrasi-kilo-alimini-onleyen-hap-gelistirildi-275299<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kilo verme s\u00fcrecinde enjeksiyon tedavisini tamamlayan hastalar\u0131n en b\u00fcy\u00fck korkusu olan &#8220;yeniden kilo alma&#8221; sorununa kar\u015f\u0131 bilim d\u00fcnyas\u0131ndan umut verici bir haber geldi. Orforglipron ad\u0131 verilen yeni bir hap\u0131n, zay\u0131flama i\u011fnelerini b\u0131rakan ki\u015filerin verdi\u011fi kilolar\u0131 muhafaza etmesini sa\u011flad\u0131\u011f\u0131 a\u00e7\u0131kland\u0131. Klinik Deneylerde Ba\u015far\u0131: Kilolar\u0131n %70&#8217;i Korunuyor Nature Medicine dergisinde yay\u0131mlanan ve Eli Lilly taraf\u0131ndan finanse edilen [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":5877,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-5876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik-haberleri"],"jetpack_featured_media_url":"https:\/\/odakhaber.site\/wp-content\/uploads\/2026\/05\/istahi-baskiliyor-zayiflama-ignesi-sonrasi-kilo-alimini-onleyen-hap-gelistirildi-off2.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/posts\/5876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/odakhaber.site\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5876"}],"version-history":[{"count":1,"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/posts\/5876\/revisions"}],"predecessor-version":[{"id":5878,"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/posts\/5876\/revisions\/5878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/odakhaber.site\/index.php?rest_route=\/wp\/v2\/media\/5877"}],"wp:attachment":[{"href":"https:\/\/odakhaber.site\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/odakhaber.site\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/odakhaber.site\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}